Optimising patient-initiated follow-up care - A qualitative analysis of women with breast cancer in the UK

被引:5
作者
Moore, Lyndel [1 ,2 ]
Matheson, Lauren [1 ,4 ]
Brett, Jo [1 ]
Lavender, Verna [1 ,5 ]
Kendall, Anne [2 ]
Lavery, Bernadette [3 ]
Watson, Eila [1 ]
机构
[1] Oxford Brookes Univ, Fac Hlth & Life Sci, Oxford OX30FL, England
[2] Great Western Hosp Fdn Trust, Swindon SN36BB, England
[3] Oxford Univ Hosp Trust, Oxford OX39DU, England
[4] Fac Hlth & Life Sci Oxford Brookes Univ, Res Fellow Oxford Inst Nursing, Midwifery & Allied Hlth Res OxINMAHR, Jack Straws Lane, Oxford OX30FL, Oxon, England
[5] Guys & St Thomas NHS Fdn Trust, Guys Canc Acad, London SE19RT, England
关键词
Breast cancer; Follow-up; Patient; -initiated; Qualitative; Self-examination; Self-management; ADJUVANT ENDOCRINE THERAPY; TAMOXIFEN;
D O I
10.1016/j.ejon.2022.102183
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Current policy in the United Kingdom (UK) recommends that people with breast cancer (PWBC) are managed in follow-up pathways that suit their needs. With an increasing trend towards patient-initiated follow-up (PIFU) pathways for PWBC, this study conducted qualitative research exploring PWBC's experiences of a nurse-led PIFU service (termed 'Supported Early Discharge') to inform how PIFU pathways could be optimised. Method: PWBC on a PIFU pathway were recruited from two UK hospitals (one large cancer centre, one district general hospital) as part of a wider mixed-methods study (N = 118). Following completion of a series of surveys, a purposive subsample of 20 women were interviewed in-depth about their experiences. Thematic analysis was conducted. Results: The majority of participants described positive views towards being on PIFU; however a significant minority struggled with uncertainties and difficulties related to: accessing ongoing care and support; performing breast self-examination (BSE); managing ongoing treatment side-effects; and fear of recurrence. Themes included: self-efficacy to manage own health; barriers and facilitators to help-seeking on a PIFU pathway; effective information sharing about side effects; preferences for personalised care; emotional wellbeing on PIFU-influences on fear of recurrence. A novel conceptual model is presented that highlights influences on self -management during PIFU. Conclusions: Findings highlight ways in which PIFU pathways could be further optimised through greater and more effective education on BSE and recognising signs of recurrence, information on when and how to seek further help with any problems, targeted provision of psychological support, and clearer signposting to support for ongoing side-effects.
引用
收藏
页数:8
相关论文
共 44 条
[1]   A systematic literature review looking for the definition of treatment burden [J].
Alsadah, Ahmed ;
van Merode, Tiny ;
Alshammari, Riyadh ;
Kleijnen, Jos .
HELIYON, 2020, 6 (04)
[2]  
[Anonymous], 2016, INN IMPL STRAT PATHW
[3]   Follow-up after curative treatment for colorectal cancer: longitudinal evaluation of patient initiated follow-up in the first 12 months [J].
Batehup, L. ;
Porter, K. ;
Gage, H. ;
Williams, P. ;
Simmonds, P. ;
Lowson, E. ;
Dodson, L. ;
Davies, N. J. ;
Wagland, R. ;
Winter, J. D. ;
Richardson, A. ;
Turner, A. ;
Corner, J. L. .
SUPPORTIVE CARE IN CANCER, 2017, 25 (07) :2063-2073
[4]   Discrimination and Medical Mistrust in a Racially and Ethnically Diverse Sample of California Adults [J].
Bazargan, Mohsen ;
Cobb, Sharon ;
Assari, Shervin .
ANNALS OF FAMILY MEDICINE, 2021, 19 (01) :4-15
[5]   Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer [J].
Beaver, Kinta ;
Martin-Hirsch, Pierre ;
Williamson, Susan ;
Kyrgiou, Maria .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2020, 44
[6]  
Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1080/14780887.2020.1769238, DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]
[7]   Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer [J].
Brett, J. ;
Fenlon, D. ;
Boulton, M. ;
Hulbert-Williams, N. J. ;
Walter, F. M. ;
Donnelly, P. ;
Lavery, B. ;
Morgan, A. ;
Morris, C. ;
Watson, E. .
EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (01)
[8]   Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer [J].
Brett, Jo ;
Boulton, Mary ;
Watson, Eila .
PATIENT PREFERENCE AND ADHERENCE, 2018, 12 :2639-2647
[9]   Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence [J].
Brett, Jo ;
Boulton, Mary ;
Fenlon, Debbie ;
Hulbert-Williams, Nick J. ;
Walter, Fiona M. ;
Donnelly, Peter ;
Lavery, Bernadette A. ;
Morgan, Adrienne ;
Morris, Carolyn ;
Watson, Eila K. .
PATIENT PREFERENCE AND ADHERENCE, 2018, 12 :291-300
[10]   Patient initiated follow up of breast cancer [J].
Brown, L ;
Payne, S ;
Royle, G .
PSYCHO-ONCOLOGY, 2002, 11 (04) :346-355